GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: A comparison with intensive lifestyle modification

62Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.

Abstract

Rapid glycemic improvements following Roux-en-Y gastric bypass (RYGB) are frequently attributed to the enhanced GLP-1 response, but causality remains unclear. To determine the role of GLP-1 in improved glucose tolerance after surgery, we compared glucose and hormonal responses to a liquid meal test in 20 obese participants with type 2 diabetes mellitus who underwent RYGB or nonsurgical intensive lifestyle modification (ILM) (n = 10 per group) before and after equivalent short-term weight reduction. The GLP-1 receptor antagonist exendin(9-39)-amide (Ex-9) was administered, in random order and in double-blinded fashion, with saline during two separate visits after equivalent weight loss. Despite the markedly exaggerated GLP-1 response after RYGB, changes in postprandial glucose and insulin responses did not significantly differ between groups, and glucagon secretion was paradoxically augmented after RYGB. Hepatic insulin sensitivity also increased significantly after RYGB. With Ex-9, glucose tolerance deteriorated similarly from the saline condition in both groups, but postprandial insulin release was markedly attenuated after RYGB compared with ILM. GLP-1 exerts important insulinotropic effects after RYGB and ILM, but the enhanced incretin response plays a limited role in improved glycemia shortly after surgery. Instead, enhanced hepatic metabolism, independent of GLP-1 receptor activation, may be more important for early postsurgical glycemic improvements.

References Powered by Scopus

Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp

4819Citations
N/AReaders
Get full text

Categorical data analysis: Away from ANOVAs (transformation or not) and towards logit mixed models

2653Citations
N/AReaders
Get full text

The physiology of glucagon-like peptide 1

2608Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

1078Citations
N/AReaders
Get full text

The incretin effect in healthy individuals and those with type 2 diabetes: Physiology, pathophysiology, and response to therapeutic interventions

349Citations
N/AReaders
Get full text

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss

153Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Vetter, M. L., Wadden, T. A., Teff, K. L., Khan, Z. F., Carvajal, R., Ritter, S., … Rickels, M. R. (2015). GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: A comparison with intensive lifestyle modification. Diabetes, 64(2), 434–446. https://doi.org/10.2337/db14-0558

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 39

66%

Researcher 13

22%

Professor / Associate Prof. 5

8%

Lecturer / Post doc 2

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 42

78%

Agricultural and Biological Sciences 5

9%

Nursing and Health Professions 4

7%

Sports and Recreations 3

6%

Save time finding and organizing research with Mendeley

Sign up for free